Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
Sandra van Bijnen, Jeska de Vries‐Bouwstra, C.H.M. van den Ende, Maaike Boonstra, L J M Lucia Kroft, Bram Geurts, Miranda Snoeren, Anne A. Schouffoer, Julia Spierings, Jacob M. van Laar, T. Huizinga, Alexandre E. Voskuyl, Erik W.A. Marijt, Walter J. F. M. van der Velden, F.H.J. van den Hoogen, Madelon C Vonk
Topics & Concepts
MedicineDLCOInternal medicineTransplantationVital capacityHematopoietic stem cell transplantationScleroderma (fungus)Diffusing capacityPulmonary function testingEjection fractionAutologous stem-cell transplantationInterstitial lung diseaseSurgeryLungImmunologyHeart failureInoculationLung functionSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisHematopoietic Stem Cell Transplantation